Panel: The Big Debate - Compensation Clawbacks: A Deterrent or Detriment? Leading Practitioners Make Their Case
This session, featuring Lowenstein partner Robert A. Johnston, will debate the pros and cons of the Program. Debate topics include:

  • Does the implementation of compensation or bonus clawbacks have the desired deterrent effect?
  • Will this have the effect of rewarding companies while unduly penalizing individual employees?
  • Is the linear connection between money and compliance realistic?
  • Will this shift the burden of corporate wrongdoing away from shareholders onto those directly responsible?
  • What are the actual requirements for a discretionary reduction?

Speakers:

  • Robert A. Johnston, Partner, Lowenstein Sandler LLP
  • Charles Duross, Partner, Morrison & Foerester
  • Aisling O’Shea, Partner, Sullivan & Cromwell LLP
  • Laura Perkins, Partner, Hughes Hubbard & Reed
  • Martin J. Weinstein, Partner, Cadwalader, Wickersham & Taft LLP

Time: 9:45 a.m. ET


Panel: Interactive Benchmarking Series: The Grey Areas of Operationalizing New DOJ Guidance and Policies

This session, featuring Lowenstein partner Rachel Maimin, will discuss:

  • Concrete examples of program upgrades and compliance pain points
  • Testing the effectiveness of your compliance program to show that it is: improving, adapting, and updating the program to ensure that it is sustainable and adapting to changing risks
  • Reviewing the qualifications and expertise of your compliance personnel
  • Rethinking resource allocation and delivery methods for training
  • Fostering and sustaining a strong corporate culture
  • Dashboards and other mechanisms for reporting

Speakers: 

  • Rachel Maimin, Partner, Lowenstein Sandler LLP
  • Lauren Kootman, Assistant Chief, Corporate Enforcement Compliance, and Policy Unit, Fraud Section, U.S. Department of Justice
  • James J. Gibson, Global Compliance Counsel, Coca-Cola
  • Natasha Trifun, Executive Director, Head of Compliance, R&D, Global Medical, External Funding & Global Functions, Alexion Pharmaceuticals, Inc.
  • Dr. Donatus Kaufmann, Strategic Executive GRC Advisor, Kaufmann & Company (Germany)

Time: 2:40 p.m. ET

Conference Location: Gaylord National Resort & Convention Center, Washington, D.C.

*Disclaimer: This event is open to the public but requires a registration fee.